warfarin – hippokratia.gr

Warfarin dose requirement in Turkish patients: the influences of patient characteristics and polymorphisms in CYP2C9, VKORC1 and factor VII

Posted on March 4, 2019July 26, 2022 by admin

ORIGINAL ARTICLE

Hippokratia 2014, 18(4):319-327

Yildirim E, Erol K, Birdane A
Pharmacology Department, Cardiology Department Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey

Be careful before prescribing warfarin and octreotide together: a new drug-drug interaction report

Posted on March 4, 2019July 26, 2022 by admin

LETTER

Hippokratia 2014, 18(4):377

Yılmaz B, Kemal Y,Teker F
Department of Medical Oncology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey

Warfarin maintenance dose associated with genetic polymorphisms of CYP2C9

Posted on March 4, 2019July 21, 2022 by admin

RESEARCH ARTICLE

Hippokratia 2017, 21(2):93-96

Khaleqsefat E, Khalaj-Kondori M, Jabbarpour Bonyadi M, Battaloğlu E
Department of Animal Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran, Department of Molecular Biology and Genetics, Boğaziçi University, Istanbul, Turkey